737 related articles for article (PubMed ID: 16882794)
21. Tandem mass spectrometry program implementation challenges for state newborn screening programs: national survey of barriers and issues.
Feuchtbaum L; Faulkner L; Verghese S
Pediatrics; 2006 May; 117(5 Pt 2):S253-60. PubMed ID: 16735251
[TBL] [Abstract][Full Text] [Related]
22. Newborn screening: current status.
Arn PH
Health Aff (Millwood); 2007; 26(2):559-66. PubMed ID: 17339686
[TBL] [Abstract][Full Text] [Related]
23. Report of the Tennessee Task Force on Screening Newborn Infants for Critical Congenital Heart Disease.
Liske MR; Greeley CS; Law DJ; Reich JD; Morrow WR; Baldwin HS; Graham TP; Strauss AW; Kavanaugh-McHugh AL; Walsh WF;
Pediatrics; 2006 Oct; 118(4):e1250-6. PubMed ID: 17015513
[TBL] [Abstract][Full Text] [Related]
24. Parental tolerance of false-positive newborn screening results.
Prosser LA; Ladapo JA; Rusinak D; Waisbren SE
Arch Pediatr Adolesc Med; 2008 Sep; 162(9):870-6. PubMed ID: 18762606
[TBL] [Abstract][Full Text] [Related]
25. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
[TBL] [Abstract][Full Text] [Related]
26. Inborn errors of metabolism and expanded newborn screening: review and update.
Mak CM; Lee HC; Chan AY; Lam CW
Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
[TBL] [Abstract][Full Text] [Related]
27. Expanded newborn screening for biochemical disorders: the effect of a false-positive result.
Gurian EA; Kinnamon DD; Henry JJ; Waisbren SE
Pediatrics; 2006 Jun; 117(6):1915-21. PubMed ID: 16740831
[TBL] [Abstract][Full Text] [Related]
28. California's experience implementing a pilot newborn supplemental screening program using tandem mass spectrometry.
Feuchtbaum L; Lorey F; Faulkner L; Sherwin J; Currier R; Bhandal A; Cunningham G
Pediatrics; 2006 May; 117(5 Pt 2):S261-9. PubMed ID: 16735252
[TBL] [Abstract][Full Text] [Related]
29. Naming and counting disorders (conditions) included in newborn screening panels.
Sweetman L; Millington DS; Therrell BL; Hannon WH; Popovich B; Watson MS; Mann MY; Lloyd-Puryear MA; van Dyck PC
Pediatrics; 2006 May; 117(5 Pt 2):S308-14. PubMed ID: 16735257
[TBL] [Abstract][Full Text] [Related]
30. Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry.
Tortorelli S; Turgeon CT; Lim JS; Baumgart S; Day-Salvatore DL; Abdenur J; Bernstein JA; Lorey F; Lichter-Konecki U; Oglesbee D; Raymond K; Matern D; Schimmenti L; Rinaldo P; Gavrilov DK
J Pediatr; 2010 Aug; 157(2):271-5. PubMed ID: 20394947
[TBL] [Abstract][Full Text] [Related]
31. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects.
Garg U; Dasouki M
Clin Biochem; 2006 Apr; 39(4):315-32. PubMed ID: 16563365
[TBL] [Abstract][Full Text] [Related]
32. [Application of tandem mass spectrometry to neonatal screening of inherited metabolic diseases: focus on present developments].
Cheillan D; Cognat S; Vianey-Saban C; Maire I; Dorche C
Ann Biol Clin (Paris); 2004; 62(3):269-77. PubMed ID: 15217759
[TBL] [Abstract][Full Text] [Related]
33. Outcomes from tandem mass spectrometry (MS/MS) workshops in the United States and the performance evaluation of MS/MS laboratories.
Hannon H; Lim T; Adam B; Therrell B
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():121-6. PubMed ID: 15906714
[TBL] [Abstract][Full Text] [Related]
34. Sani-cloth wipe mimics rare enzyme deficiency malonic aciduria on newborn screen.
Reindl BA; Lynch DW; Ramirez M; Valbracht M; Davis-Keppen L; Tams KC; Groeneveld S
Pediatrics; 2012 Nov; 130(5):e1363-8. PubMed ID: 23071203
[TBL] [Abstract][Full Text] [Related]
35. CDC Grand Rounds: Newborn screening and improved outcomes.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(21):390-3. PubMed ID: 22647744
[TBL] [Abstract][Full Text] [Related]
36. Newborn screening.
Sahai I; Marsden D
Crit Rev Clin Lab Sci; 2009; 46(2):55-82. PubMed ID: 19255915
[TBL] [Abstract][Full Text] [Related]
37. Newborn screening of inborn errors of metabolism by capillary electrophoresis-electrospray ionization-mass spectrometry: a second-tier method with improved specificity and sensitivity.
Chalcraft KR; Britz-McKibbin P
Anal Chem; 2009 Jan; 81(1):307-14. PubMed ID: 19117458
[TBL] [Abstract][Full Text] [Related]
38. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
Wilfond BS; Gollust SE
J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
[TBL] [Abstract][Full Text] [Related]
39. Expanded newborn screening for genetic and metabolic disorders: modeling costs and outcomes.
Hubbard HB
Nurs Econ; 2007; 25(6):345-52. PubMed ID: 18240836
[TBL] [Abstract][Full Text] [Related]
40. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs.
la Marca G; Malvagia S; Pasquini E; Innocenti M; Fernandez MR; Donati MA; Zammarchi E
Rapid Commun Mass Spectrom; 2008; 22(6):812-8. PubMed ID: 18278819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
